American BioSources Inc d/b/a Genomic Diagnostics is a healthcare company based in the United States, we operate in the US and worldwide under two divisions: Biopharmaceuticals and Diagnostics. Genomic Diagnostics is a privately held company headquartered in Washington, New Jersey, USA.
Genomic Diagnostics researches, develops, manufactures bacterial and viral diagnostic kits, reagents, reference standards for research and medical diagnostic applications. Internally, it is organized into two business divisions:
All business areas focus on health care applications, targeting physicians, hospitals, government contracts, clinics, or consumers. Life Science targets research settings in academia and pharmaceutical and biotechnology industries.
Dr. Niranjan Kumar leads Genomic Diagnostics research and invention team, he was the first to develop and validate the amplification of RNA in In Vitro (Peripheral Blood Mononuclear Cells) and In Vivo (Lung Tissue) in 1996. Dr. Kumar’s innovative technique of RT-PCR in tissue and in the cell was well-received, presented and published in the International Conference (ASC, 1995) and Peer Reviewed Journals.
Since then there were number of publications using this technique for developing novel diagnostics at the gene level.
Dr. Kumar developed quantitative RT-PCR, multiple gene amplification in one reaction/one tube. These genes were normalized against the control gene and quantified. Dr. Kumar’s work was published in the peer-reviewed journals.
Genomic Diagnostics is actively in search of identifying and quantifying various emerging pathogenic viruses and bacteria at RNA/DNA and protein levels. Our scientists, clinicians and laboratory technicians work collaboratively to develop and validate the methods/tests for research, diagnostics and biopharmaceutical applications. Our extensive (collectively over 60 years) experience has positioned us as the most innovative, precise and quality diagnostic & biopharmaceutical product developers and service providers.